excedrin pm triple action caplets

Generic: acetaminophen, aspirin (nsaid) and diphenhydramine citrate

Labeler: haleon us holdings llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name excedrin pm triple action caplets
Generic Name acetaminophen, aspirin (nsaid) and diphenhydramine citrate
Labeler haleon us holdings llc
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

acetaminophen 250 mg/1, aspirin 250 mg/1, diphenhydramine citrate 38 mg/1

Manufacturer
Haleon US Holdings LLC

Identifiers & Regulatory

Product NDC 0067-2056
Product ID 0067-2056_8304e801-1a21-42b1-ad99-dd8621be478a
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2014-09-24

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00672056
Hyphenated Format 0067-2056

Supplemental Identifiers

RxCUI
1593110 1593116
UNII
362O9ITL9D R16CO5Y76E 4OD433S209
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name excedrin pm triple action caplets (source: ndc)
Generic Name acetaminophen, aspirin (nsaid) and diphenhydramine citrate (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
  • 38 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (0067-2056-24) / 24 TABLET, COATED in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (0067-2056-91) / 100 TABLET, COATED in 1 BOTTLE
source: ndc

Packages (2)

Ingredients (3)

acetaminophen (250 mg/1) aspirin (250 mg/1) diphenhydramine citrate (38 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8304e801-1a21-42b1-ad99-dd8621be478a", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["362O9ITL9D", "R16CO5Y76E", "4OD433S209"], "rxcui": ["1593110", "1593116"], "spl_set_id": ["b3812d27-40af-40d7-864a-dfa4ae34cb9e"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Haleon US Holdings LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2056-24)  / 24 TABLET, COATED in 1 BOTTLE", "package_ndc": "0067-2056-24", "marketing_start_date": "20140924"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2056-91)  / 100 TABLET, COATED in 1 BOTTLE", "package_ndc": "0067-2056-91", "marketing_start_date": "20140924"}], "brand_name": "Excedrin PM Triple Action Caplets", "product_id": "0067-2056_8304e801-1a21-42b1-ad99-dd8621be478a", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "0067-2056", "generic_name": "Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate", "labeler_name": "Haleon US Holdings LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Excedrin PM Triple Action Caplets", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "DIPHENHYDRAMINE CITRATE", "strength": "38 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20140924", "listing_expiration_date": "20261231"}